153 related articles for article (PubMed ID: 35068360)
1. Synthesis of novel pancreatic lipase inhibitors: Biological investigation and
Mermer A; Demirci S; Tatar G
J Biomol Struct Dyn; 2022 Feb; 40(2):931-940. PubMed ID: 35068360
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular modelling,
S N C S; Sengupta P; Palawat S; P S D; George G; Paul AT
J Biomol Struct Dyn; 2022; 40(19):9530-9542. PubMed ID: 34032197
[TBL] [Abstract][Full Text] [Related]
3. Discovery of thiazolidinedione-based pancreatic lipase inhibitors as anti-obesity agents: synthesis,
Dhiman P; Yadav N; Auti PS; Jaswal S; Singh G; Mehan S; Ghosh B; Paul AT; Monga V
J Biomol Struct Dyn; 2024 Feb; ():1-23. PubMed ID: 38315459
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation and molecular modelling studies of indole glyoxylamides as a new class of potential pancreatic lipase inhibitors.
Sridhar SNC; Palawat S; Paul AT
Bioorg Chem; 2019 Apr; 85():373-381. PubMed ID: 30658237
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Spectral Identification of Three Schiff Bases with a 2-(Piperazin-1-yl)-
Warad I; Ali O; Al Ali A; Jaradat NA; Hussein F; Abdallah L; Al-Zaqri N; Alsalme A; Alharthi FA
Molecules; 2020 May; 25(9):. PubMed ID: 32403218
[TBL] [Abstract][Full Text] [Related]
6. In Silico and in Vitro Biological Evaluation of Novel Serial Sulfonate Derivatives on Pancreatic Lipase Activity.
Yetişsin F; Korkmaz A; Kaya E
Chem Biodivers; 2023 Nov; 20(11):e202301210. PubMed ID: 37743258
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors.
S N C S; Bhurta D; Kantiwal D; George G; Monga V; Paul AT
Bioorg Med Chem Lett; 2017 Aug; 27(16):3749-3754. PubMed ID: 28705641
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new 1,4-disubstituted 1,2,3-triazoles:
Şahin İ; Çeşme M; Yüce N; Tümer F
J Biomol Struct Dyn; 2023 Mar; 41(5):1988-2001. PubMed ID: 35057704
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, evaluation, and molecular modeling studies of indolyl oxoacetamides as potential pancreatic lipase inhibitors.
Sridhar SNC; Palawat S; Paul AT
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000048. PubMed ID: 32484265
[TBL] [Abstract][Full Text] [Related]
10. Design, in silico study, synthesis and in vitro evaluation of some N5-(1H-pyrazol-3-yl)-3H-benzo[d]imidazole-2,5-diamine derivatives as potential pancreatic lipase inhibitors for anti-obesity activity.
Unnisa A; Huwaimel B; Almahmoud S; Abouzied AS; Younes KM; Anupama B; Kola PK; Lakshmi NVKC
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7245-7255. PubMed ID: 36263535
[TBL] [Abstract][Full Text] [Related]
11. Molecular modelling, synthesis and
George G; Yadav N; Auti PS; Paul AT
J Biomol Struct Dyn; 2023 Nov; 41(19):9583-9601. PubMed ID: 36350239
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors.
Chauhan D; George G; Sridhar SNC; Bhatia R; Paul AT; Monga V
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900029. PubMed ID: 31407389
[TBL] [Abstract][Full Text] [Related]
13. A computational study to probe the binding aspects of potent polyphenolic inhibitors of pancreatic lipase.
Kottekad S; Roy S; Dandamudi U
J Biomol Struct Dyn; 2024 Apr; 42(7):3472-3491. PubMed ID: 37199285
[TBL] [Abstract][Full Text] [Related]
14. Exploring Aurone Derivatives as Potential Human Pancreatic Lipase Inhibitors through Molecular Docking and Molecular Dynamics Simulations.
Nguyen PTV; Huynh HA; Truong DV; Tran TD; Vo CT
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066044
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors.
Menteşe E; Yılmaz F; Emirik M; Ülker S; Kahveci B
Bioorg Chem; 2018 Feb; 76():478-486. PubMed ID: 29306066
[TBL] [Abstract][Full Text] [Related]
16. Anti-obesity, antioxidant and in silico evaluation of Justicia carnea bioactive compounds as potential inhibitors of an enzyme linked with obesity: Insights from kinetics, semi-empirical quantum mechanics and molecular docking analysis.
Anigboro AA; Avwioroko OJ; Akeghware O; Tonukari NJ
Biophys Chem; 2021 Jul; 274():106607. PubMed ID: 33957576
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.
Huo PC; Hu Q; Shu S; Zhou QH; He RJ; Hou J; Guan XQ; Tu DZ; Hou XD; Liu P; Zhang N; Liu ZG; Ge GB
Bioorg Med Chem; 2021 Jan; 29():115853. PubMed ID: 33214035
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, evaluation and molecular modelling studies of 2-(carbazol-3-yl)-2-oxoacetamide analogues as a new class of potential pancreatic lipase inhibitors.
Sridhar SN; Ginson G; Venkataramana Reddy PO; Tantak MP; Kumar D; Paul AT
Bioorg Med Chem; 2017 Jan; 25(2):609-620. PubMed ID: 27908755
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Activity and Molecular Docking Studies of Novel Sulfonate Derivatives Bearing Salicylaldehyde.
Korkmaz A; Bursal E
Chem Biodivers; 2022 Jun; 19(6):e202200140. PubMed ID: 35561156
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, spectroscopic characterizations,
Korkmaz A; Kurtay G; Kaya E; Bursal E
J Biomol Struct Dyn; 2023; 41(15):7128-7143. PubMed ID: 36069113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
